This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2024 Jun;80(6):e256-e257.

doi: 10.1016/j.jhep.2023.11.014. Epub 2023 Nov 28.

ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort

Beata Kruk¹, Roman Liebe², Susanne N Weber³, Piotr Milkiewicz⁴, Marcin Krawczyk⁵

Affiliations

Affiliations

¹ Laboratory of Metabolic Liver Diseases, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
² Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Magdeburg, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
³ Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.
⁴ Liver and Internal Medicine Unit, Medical University of Warsaw, Warsaw, Poland; Translational Medicine Group, Pomeranian Medical University in Szczecin, Szczecin, Poland.
⁵ Laboratory of Metabolic Liver Diseases, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland; Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany. Electronic address: marcin.krawczyk@uks.eu.

PMID: 38036008
DOI: 10.1016/j.jhep.2023.11.014

Comment

ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort

Beata Kruk et al. J Hepatol. 2024 Jun.

. 2024 Jun;80(6):e256-e257.

doi: 10.1016/j.jhep.2023.11.014. Epub 2023 Nov 28.

Authors

Beata Kruk¹, Roman Liebe², Susanne N Weber³, Piotr Milkiewicz⁴, Marcin Krawczyk⁵

Affiliations

¹ Laboratory of Metabolic Liver Diseases, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
² Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Magdeburg, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
³ Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.
⁴ Liver and Internal Medicine Unit, Medical University of Warsaw, Warsaw, Poland; Translational Medicine Group, Pomeranian Medical University in Szczecin, Szczecin, Poland.
⁵ Laboratory of Metabolic Liver Diseases, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland; Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany. Electronic address: marcin.krawczyk@uks.eu.

PMID: 38036008
DOI: 10.1016/j.jhep.2023.11.014

No abstract available

PubMed Disclaimer

Comment in

Reply to: "ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort".
Tang R, Li Y, Chen R, Ma X. Tang R, et al. J Hepatol. 2024 Jun;80(6):e258-e259. doi: 10.1016/j.jhep.2024.01.016. Epub 2024 Jan 30. J Hepatol. 2024. PMID: 38301828 No abstract available.

Comment on

A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.
Chen R, Huang B, Lian M, Wei Y, Miao Q, Liang J, Ou Y, Liang X, Zhang H, Li Y, Xiao X, Wang Q, You Z, Chai J, Gershwin ME, Tang R, Ma X. Chen R, et al. J Hepatol. 2023 Dec;79(6):1478-1490. doi: 10.1016/j.jhep.2023.08.016. Epub 2023 Sep 1. J Hepatol. 2023. PMID: 37659731

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Molecular Biology Databases
- GlyGen glycoinformatics resource